Bayer is looking for partners for its manmade fibers business

25-Apr-2001

Following the divestment of the Dralon acrylic fiber business, the Bayer Group no longer defines its remaining fibers operations, comprising Dorlastan spandex fiber and Perlon monofil, as part of its core business. It is therefore actively looking for partners for these global activities. Divestment is also an option. The background to this decision is the streamlining of the group's portfolio and the ongoing structural change in the manmade fibers industry.

The aim is to find a partner or purchaser who provides scope to utilize development opportunities for these activities and safeguard their technological edge through further investment.

Consolidated sales of Bayer's Dorlastan and Monofil business units are around €250 million, and they employ a total of some 1,000 people at the sites in Dormagen and Goch, Germany, and Bushy Park, U.S.A.

Other news from the department

Most read news

More news from our other portals

Discover the latest developments in battery technology!